概括
在白血病细胞上发现的一种新型7.5万达尔顿蛋白 (p75) 含有病毒核心成分,可能是糖化. 它的存在增加了白血病前小鼠的胸细胞.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 鼠类白血病病毒 (MuLV) 与AKR小鼠的自发白血病有关.
- 细胞表面蛋白质在细胞相互作用和免疫反应中起着至关重要的作用.
- 了解病毒蛋白的表达是解读白血病病变的关键.
研究的目的:
- 识别和描述AKR自发白血病细胞上的新型蛋白质.
- 调查已识别的蛋白质的潜在病毒起源和糖化状态.
- 在AKR小鼠中,将这些蛋白质的表达与白血病前变化的进展相关联.
主要方法:
- 乳氧化酶催化放射性以标记表面蛋白质.
- 免疫沉以确定抗原决定因素.
- 放射性葡萄糖胺的结合,以评估糖化.
主要成果:
- 在AKR自发白血病细胞上发现了75,000达尔顿的多 (p75).
- p75 具有 MuLV 核心蛋白 (p30,p15,p10) 的抗原决定因素,但没有 gp70.
- p75可能是糖化,其表达在患白血病前AKR小鼠的胸细胞上随着年龄的增长而增加.
结论:
- p75 是一种可能在AKR白血病细胞上表达的MuLV核心成分的糖化聚蛋白.
- 乳房细胞p75的年龄相关增加表明它参与了白血病前的发展.
- 进一步对p75的研究可以提供有关MuLV诱导的白血病发生的见解.
相关概念视频
Heart Failure V: Medical Management
224
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
224
Myocarditis III: Medical Management
179
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
179
Endocarditis III: Medical Management
217
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
217
06:59A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
31.1K
This study presents a novel device that offers an easy route to quickly provide medications and fluids in patients with limited or difficult IV access. This small-diameter device is placed in the distal third of the rectum, allowing for ongoing medication and fluids...
31.1K
Inhaled Medications
757
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
757
Preparing and Administering Inhaled Medications
38.2K
Source: Madeline Lassche, MSNEd, RN and Katie Baraki, MSN, RN, College of Nursing, University of Utah, UT
Inhaled medications are prescribed for conditions affecting the bronchi, which branch off of the trachea, and bronchioles, which are progressively smaller conducting airways spread throughout the lung tissue. These conditions can be classified as acute (i.e., temporary, with quick onset) or chronic (i.e., persistent and/or recurrent symptoms lasting months to years). Common acute conditions...
Inhaled medications are prescribed for conditions affecting the bronchi, which branch off of the trachea, and bronchioles, which are progressively smaller conducting airways spread throughout the lung tissue. These conditions can be classified as acute (i.e., temporary, with quick onset) or chronic (i.e., persistent and/or recurrent symptoms lasting months to years). Common acute conditions...
38.2K
